Emily Woodworth
Known title: SVP, Global Controller and CAOCIK: 0002013518
Associated companies
Transaction History
| BSX | ▼ Sell | Other | 2,930 | $150K | 8/11/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 838 | $0 | 3/1/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 372 | $29K | 3/1/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 283 | $21K | 2/16/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 637 | $0 | 2/16/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 661 | $0 | 2/14/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 296 | $22K | 2/14/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,413 | $0 | 2/13/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 690 | $52K | 2/13/2026 | View on chart |
| BSX | ▲ Buy | Option Exercise | 481 | $0 | 2/12/2026 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 242 | $18K | 2/12/2026 | View on chart |
| BSX | ▼ Sell | Open Market | 482 | $50K | 3/4/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 5,949 | $223K | 3/3/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 7,149 | $750K | 3/3/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 837 | $0 | 3/1/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 355 | $37K | 3/1/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 7,218 | $304K | 2/28/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 9,887 | $1000K | 2/28/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 667 | $0 | 2/17/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 283 | $30K | 2/17/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 636 | $0 | 2/16/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 271 | $29K | 2/16/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 661 | $0 | 2/14/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 315 | $33K | 2/14/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 480 | $0 | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 231 | $24K | 2/12/2025 | View on chart |
| BSX | ▼ Sell | Open Market | 1,336 | $121K | 11/27/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate
Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.